Pain Relief Investigation of NeuroModulation Therapy in Adult Humans

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00253032
Recruitment Status : Terminated
First Posted : November 15, 2005
Last Update Posted : March 3, 2006
Information provided by:
Fralex Therapeutics

Brief Summary:
The study is being performed to determine the efficacy and safety of Fralex Neuromodulation Therapy (F-NMT), delivered by the Fralex PRIMA device, in reducing chronic musculoskeletal pain.

Condition or disease Intervention/treatment Phase
Chronic Musculoskeletal Pain Device: PRIMA Phase 3

Study Type : Interventional  (Clinical Trial)
Official Title: PRIMA Study: Pain Relief Investigation of NeuroModulation Therapy in an Adult Population: A Double Blind, Randomized, Multicenter, Placebo Controlled Trial.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   Child, Adult, Senior Identifier: NCT00253032     History of Changes
Other Study ID Numbers: F05001
First Posted: November 15, 2005    Key Record Dates
Last Update Posted: March 3, 2006
Last Verified: March 2006

Additional relevant MeSH terms:
Musculoskeletal Pain
Muscular Diseases
Musculoskeletal Diseases
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms